.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Cipla
US Department of Justice
Fuji
Chubb
Daiichi Sankyo
US Army
Mallinckrodt
Accenture
Deloitte

Generated: June 27, 2017

DrugPatentWatch Database Preview

TERAZOSIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Terazosin Hydrochloride, and what generic Terazosin Hydrochloride alternatives are available?

Terazosin Hydrochloride is a drug marketed by Ivax Sub Teva Pharms, Sandoz, Jubilant Cadista, Ranbaxy Labs Ltd, Mylan Pharms Inc, Teva, Mylan Technologies, and Apotex. and is included in twelve NDAs.

The generic ingredient in TERAZOSIN HYDROCHLORIDE is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.

Summary for Tradename: TERAZOSIN HYDROCHLORIDE

Patents:0
Applicants:8
NDAs:12
Suppliers / Packagers: see list27
Bulk Api Vendors: see list42
Clinical Trials: see list2,256
Patent Applications: see list736
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TERAZOSIN HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: TERAZOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Technologies
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL075384-001Dec 1, 2000DISCNNoNo► Subscribe► Subscribe
Teva
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
TABLET;ORAL074446-004May 18, 2000DISCNNoNo► Subscribe► Subscribe
Apotex
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL075498-001Apr 12, 2001ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL075140-004Feb 11, 2000ABRXNoNo► Subscribe► Subscribe
Sandoz
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
TABLET;ORAL074657-001Apr 28, 2000DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Cipla
Express Scripts
Teva
Cantor Fitzgerald
US Department of Justice
McKesson
Mallinckrodt
Chinese Patent Office
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot